Abstract
Background: It is controversial if urothelial carcinoma of the bladder with squamous and/or glandular differentiation is a more aggressive neoplasm than conventional urothelial carcinoma. Design: A total of 165 transurethral resections of the bladder were reviewed. A group with squamous and//or glandular differentiation was compared to a group without this finding. The qui-square test was used to assess the association of the groups with stage (TNM, 1997).Results: Of the total of 165 transurethral resections of the bladder, 153 (92.72%) were conventional urothelial carcinomas and 12 (7.27%) showed squamous and/or glandular differentiation. The distribution according to stage was 84 (54.9%), 35 (22.9%) and 34 (22.2%) for the group without differentiation and 0 (0%) 3 (25%) and 9 (75%) for the group with squamous and/or glandular differentiation, respectively for stages pTa, pT1 and pT2. Tumors with squamous and/or glandular differentiation showed a significant statistical correlation to higher stage at clinical presentation (p <0.0001). There was no significant statistical relation according to age (p = 0.8433), sex (p = 0.5672) or race (p = 0.3137). Conclusions: The results suggest that urothelial bladder carcinomas with squamous and/or glandular differentiation are more aggressive neoplasms. There was a significant statistical correlation between tumors with this differentiation and higher stage at clinical presentation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Grignon DJ. Neoplasms of the urinary bladder. In: Bostwick DG, Eble JN, eds. Urologic Surgical Pathology. St. Louis: Mosby, 1977: 214–305.
Sakamoto N, Tsuneyoshi M, Enjoji M. Urinary bladder carcinoma with neoplastic squamous component: a mapping study of 31 cases. Histopathology 1992; 21: 135–141.
Martin JE, Jenkins BJ, Zuk RJ et al. Clinical importance of squamous metaplasia in invasive transitional cell carcinoma of the bladder. J Clin Pathol 1989; 42: 250–253.
Grace DA, Winter CC. Mixed differentiation of primary carcinoma of the urinary bladder. Cancer 1968; 21: 1239–1243.
Fegen JP, Albert DJ, Persky L. Adenocarcinoma and transitional cell carcinoma occurring simultaneously in the urinary bladder (mixed tumor). J Surg Oncol 1971; 3: 387–392.
International Union Against Cancer. TNM. Classification of Malignant Tumours, 5th edn. New York: Wiley-Liss, 1997: 187–190.
Frazier HA, Robertson JE, Dodge RK, Paulson DF. The value of pathologic factors in predicting cancer-specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate. Cancer 1993; 71: 3993–4001.
Akdas A, Turkeri L. The impact of squamous metaplasia in transitional cell carcinoma of the bladder. Int Urol Nephrol 1991; 23: 333–336.
Logothetis CJ, Dexeus FH, Chong C et al. Cisplatin, cyclophosphamide and doxorubicin chemotherapy for unresectable urothelial tumors: the MD Anderson experience. J Urol 1989; 141: 33–37.
Genega EM, Hutchinson B, Hashibe M et al. Urothelial carcinoma with aberrant differentiation: incidence and clinical significance. Mod Pathol 2000; 13: 100A.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Billis, A., Schenka, A.A., Ramos, C.C. et al. Squamous and/or glandular differentiation in urothelial carcinoma: Prevalence and significance in transurethral resections of the bladder. Int Urol Nephrol 33, 631–633 (2001). https://doi.org/10.1023/A:1020597611645
Issue Date:
DOI: https://doi.org/10.1023/A:1020597611645